A Synopsis of Some Biotech Companies’ Events

Synopsis
The way many bloggers are interpreting the quarterly and yearly biotech companies’ financial results seems unfair and has proven to be.
Amgen
Amgen (AMGN): The stock gained over $10 yesterday and is trading now at $231. Many bloggers continue to attack the firm, mourning the loss of their protective patents on its over 30 years’ old products and ignore the record . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.